| UniProt ID | ARK72_HUMAN | |
|---|---|---|
| UniProt AC | O43488 | |
| Protein Name | Aflatoxin B1 aldehyde reductase member 2 | |
| Gene Name | AKR7A2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 359 | |
| Subcellular Localization | Golgi apparatus. Cytoplasm . | |
| Protein Description | Catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. May have an important role in producing the neuromodulator gamma-hydroxybutyrate (GHB). Has broad substrate specificity. Has NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde and pyridine-2-aldehyde (in vitro). Can reduce 1,2-naphthoquinone and 9,10-phenanthrenequinone (in vitro). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.. | |
| Protein Sequence | MLSAASRVVSRAAVHCALRSPPPEARALAMSRPPPPRVASVLGTMEMGRRMDAPASAAAVRAFLERGHTELDTAFMYSDGQSETILGGLGLGLGGGDCRVKIATKANPWDGKSLKPDSVRSQLETSLKRLQCPQVDLFYLHAPDHGTPVEETLHACQRLHQEGKFVELGLSNYASWEVAEICTLCKSNGWILPTVYQGMYNATTRQVETELFPCLRHFGLRFYAYNPLAGGLLTGKYKYEDKDGKQPVGRFFGNSWAETYRNRFWKEHHFEAIALVEKALQAAYGASAPSVTSAALRWMYHHSQLQGAHGDAVILGMSSLEQLEQNLAATEEGPLEPAVVDAFNQAWHLVAHECPNYFR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Phosphorylation | SAASRVVSRAAVHCA CHHHHHHHHHHHHHH | 17.22 | - | |
| 20 | Phosphorylation | AVHCALRSPPPEARA HHHHHHCCCCHHHHH | 42.48 | 26657352 | |
| 31 | Phosphorylation | EARALAMSRPPPPRV HHHHHHHCCCCCHHH | 35.71 | 26657352 | |
| 40 | Phosphorylation | PPPPRVASVLGTMEM CCCHHHHHHHCCHHH | 18.28 | 19060867 | |
| 51 | Sulfoxidation | TMEMGRRMDAPASAA CHHHHHCCCCHHHHH | 5.06 | 21406390 | |
| 56 | Phosphorylation | RRMDAPASAAAVRAF HCCCCHHHHHHHHHH | 19.85 | 21406692 | |
| 61 | Methylation | PASAAAVRAFLERGH HHHHHHHHHHHHCCC | 18.20 | - | |
| 78 | Phosphorylation | LDTAFMYSDGQSETI CEEEEECCCCCCCEE | 24.39 | 50564499 | |
| 105 | Ubiquitination | CRVKIATKANPWDGK EEEEEEECCCCCCCC | 36.82 | - | |
| 105 | Acetylation | CRVKIATKANPWDGK EEEEEEECCCCCCCC | 36.82 | 25953088 | |
| 112 | Ubiquitination | KANPWDGKSLKPDSV CCCCCCCCCCCHHHH | 50.58 | - | |
| 113 | Phosphorylation | ANPWDGKSLKPDSVR CCCCCCCCCCHHHHH | 47.34 | 26437602 | |
| 115 | Ubiquitination | PWDGKSLKPDSVRSQ CCCCCCCCHHHHHHH | 54.60 | - | |
| 118 | Phosphorylation | GKSLKPDSVRSQLET CCCCCHHHHHHHHHH | 28.14 | 23312004 | |
| 121 | Phosphorylation | LKPDSVRSQLETSLK CCHHHHHHHHHHHHH | 36.64 | 26437602 | |
| 128 | Ubiquitination | SQLETSLKRLQCPQV HHHHHHHHHHCCCCE | 51.32 | 2190698 | |
| 128 | Acetylation | SQLETSLKRLQCPQV HHHHHHHHHHCCCCE | 51.32 | 25953088 | |
| 223 | Phosphorylation | RHFGLRFYAYNPLAG HHHCCEEEEECCCCC | 11.18 | 20090780 | |
| 225 | Phosphorylation | FGLRFYAYNPLAGGL HCCEEEEECCCCCCC | 13.11 | 20090780 | |
| 236 | Ubiquitination | AGGLLTGKYKYEDKD CCCCCCEEEEEECCC | 33.08 | 21890473 | |
| 236 | Succinylation | AGGLLTGKYKYEDKD CCCCCCEEEEEECCC | 33.08 | - | |
| 236 | Acetylation | AGGLLTGKYKYEDKD CCCCCCEEEEEECCC | 33.08 | 25953088 | |
| 236 | Succinylation | AGGLLTGKYKYEDKD CCCCCCEEEEEECCC | 33.08 | 21890473 | |
| 238 | Acetylation | GLLTGKYKYEDKDGK CCCCEEEEEECCCCC | 45.72 | 26051181 | |
| 239 | Phosphorylation | LLTGKYKYEDKDGKQ CCCEEEEEECCCCCC | 26.69 | 26657352 | |
| 250 | Methylation | DGKQPVGRFFGNSWA CCCCCCHHHCCCCHH | 24.77 | - | |
| 255 | Phosphorylation | VGRFFGNSWAETYRN CHHHCCCCHHHHHHH | 28.21 | 22617229 | |
| 259 | Phosphorylation | FGNSWAETYRNRFWK CCCCHHHHHHHHHHH | 21.75 | 20068231 | |
| 260 | Phosphorylation | GNSWAETYRNRFWKE CCCHHHHHHHHHHHH | 9.44 | 24117733 | |
| 284 | Phosphorylation | EKALQAAYGASAPSV HHHHHHHHCCCCCHH | 19.08 | 25867546 | |
| 287 | Phosphorylation | LQAAYGASAPSVTSA HHHHHCCCCCHHHHH | 36.03 | 20068231 | |
| 290 | Phosphorylation | AYGASAPSVTSAALR HHCCCCCHHHHHHHH | 37.43 | 25867546 | |
| 292 | Phosphorylation | GASAPSVTSAALRWM CCCCCHHHHHHHHHH | 19.58 | 25867546 | |
| 293 | Phosphorylation | ASAPSVTSAALRWMY CCCCHHHHHHHHHHH | 14.91 | 25867546 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ARK72_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARK72_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARK72_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ARK73_HUMAN | AKR7A3 | physical | 16189514 | |
| ARK72_HUMAN | AKR7A2 | physical | 25416956 | |
| DUS12_HUMAN | DUSP12 | physical | 26344197 | |
| PRS4_HUMAN | PSMC1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY. | |